Matches in Wikidata for { <http://www.wikidata.org/entity/Q66394358> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q66394358 description "clinical trial" @default.
- Q66394358 description "ensayu clínicu" @default.
- Q66394358 description "klinisch onderzoek" @default.
- Q66394358 description "клінічне випробування" @default.
- Q66394358 name "JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors" @default.
- Q66394358 name "JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors" @default.
- Q66394358 type Item @default.
- Q66394358 label "JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors" @default.
- Q66394358 label "JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors" @default.
- Q66394358 prefLabel "JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors" @default.
- Q66394358 prefLabel "JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors" @default.
- Q66394358 P1132 Q66394358-39B9BF91-4211-424A-9FCD-F3C9CD35D799 @default.
- Q66394358 P1476 Q66394358-0FA549A9-70B8-49AE-A9F0-DBF0B5C36A91 @default.
- Q66394358 P17 Q66394358-9118AC88-18B7-4295-BA9E-ACD22A143921 @default.
- Q66394358 P1813 Q66394358-77407616-51EE-4154-96F7-3890AD09B246 @default.
- Q66394358 P2899 Q66394358-3EB14712-651F-4041-A65E-C0D24F07E065 @default.
- Q66394358 P3098 Q66394358-4176F4F2-3307-4841-B7D5-445648F5BC54 @default.
- Q66394358 P31 Q66394358-B634FE6D-BFB1-4206-BA32-CE37F4C76185 @default.
- Q66394358 P4844 Q66394358-7AF9290B-BABD-40C1-8A5F-59992F92B550 @default.
- Q66394358 P4844 Q66394358-A6DD80E5-65F5-478D-937B-90E64B80BF90 @default.
- Q66394358 P580 Q66394358-41A1F578-2262-44FB-ACBF-51ABDF1D4CD1 @default.
- Q66394358 P582 Q66394358-B1D8F3FA-BA21-4877-AED3-F4E3ADFC2659 @default.
- Q66394358 P6099 Q66394358-27B033B8-BAE2-4E90-A067-F657F4749784 @default.
- Q66394358 P6099 Q66394358-D43DA1E6-92DD-457D-A928-356FB24344D8 @default.
- Q66394358 P8363 Q66394358-FF22CCC7-BE4B-4679-BCB2-7BC8B09782F2 @default.
- Q66394358 P921 Q66394358-15CF784F-5BED-402C-B8D2-609D48E089F4 @default.
- Q66394358 P1132 "+242" @default.
- Q66394358 P1476 "Phase 1/2 Multicenter Trial of ICOS Agonist Monoclonal Antibody (mAb) JTX-2011 Alone and in Combination With Nivolumab, Ipilimumab, or Pembrolizumab in Adult Subjects With Advanced and/or Refractory Solid Tumor Malignancies" @default.
- Q66394358 P17 Q30 @default.
- Q66394358 P1813 "ICONIC" @default.
- Q66394358 P2899 "+18" @default.
- Q66394358 P3098 "NCT02904226" @default.
- Q66394358 P31 Q30612 @default.
- Q66394358 P4844 Q13896859 @default.
- Q66394358 P4844 Q50429626 @default.
- Q66394358 P580 "2016-08-01T00:00:00Z" @default.
- Q66394358 P582 "2020-12-01T00:00:00Z" @default.
- Q66394358 P6099 Q42824440 @default.
- Q66394358 P6099 Q5452194 @default.
- Q66394358 P8363 Q78089383 @default.
- Q66394358 P921 Q7041828 @default.